Copy to clipboard 
X-Bolt Orthopedics’ Pro-X1 Trochanteric Nail received an Innovative Technology contract from Vizient, a U.S. provider-driven healthcare performance improvement company. The contract was awarded based on review of the Pro-X1 Trochanteric Nail from hospital experts who serve on one of Vizient’s client-led councils, and it signifies to Vizient clients its unique qualities that potentially bring improvement to the healthcare industry.
Pro-X1 is designed to address the limitations of conventional lag screw fixation in osteoporotic bone by expanding within the femoral head to increase surface area and resistance to cut-out. By providing enhanced fixation stability without additional procedural complexity, the technology has the potential to improve surgical confidence, reduce fixation-related complications, and support more consistent outcomes in hip fracture patients.
“Hip fracture fixation remains one of the most challenging and consequential procedures performed in trauma care,” said Philip Kemp, President and COO of X-Bolt Orthopedics. “Receiving an Innovative Technology contract from Vizient is a strong validation of the clinical need our expandable bolt technology is designed to address. We are excited to be on contract with Vizient to help expand national access to a solution that aims to improve fixation stability in compromised bone and support better outcomes for this vulnerable patient population.”
Vizient’s client base includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute healthcare providers and has a portfolio that represents more than $156 billion in annual purchasing volume. Through its Innovative Technology Program, Vizient works with client-led councils and task forces to evaluate products for their potential to bring real innovation to healthcare. If it is determined that a product is innovative, Vizient may award a contract outside of the competitive bid cycle.
Source: X-Bolt Orthopedics
X-Bolt Orthopedics' Pro-X1 Trochanteric Nail received an Innovative Technology contract from Vizient, a U.S. provider-driven healthcare performance improvement company. The contract was awarded based on review of the Pro-X1 Trochanteric Nail from hospital experts who serve on one of Vizient's client-led councils, and it signifies to Vizient...
X-Bolt Orthopedics’ Pro-X1 Trochanteric Nail received an Innovative Technology contract from Vizient, a U.S. provider-driven healthcare performance improvement company. The contract was awarded based on review of the Pro-X1 Trochanteric Nail from hospital experts who serve on one of Vizient’s client-led councils, and it signifies to Vizient clients its unique qualities that potentially bring improvement to the healthcare industry.
Pro-X1 is designed to address the limitations of conventional lag screw fixation in osteoporotic bone by expanding within the femoral head to increase surface area and resistance to cut-out. By providing enhanced fixation stability without additional procedural complexity, the technology has the potential to improve surgical confidence, reduce fixation-related complications, and support more consistent outcomes in hip fracture patients.
“Hip fracture fixation remains one of the most challenging and consequential procedures performed in trauma care,” said Philip Kemp, President and COO of X-Bolt Orthopedics. “Receiving an Innovative Technology contract from Vizient is a strong validation of the clinical need our expandable bolt technology is designed to address. We are excited to be on contract with Vizient to help expand national access to a solution that aims to improve fixation stability in compromised bone and support better outcomes for this vulnerable patient population.”
Vizient’s client base includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute healthcare providers and has a portfolio that represents more than $156 billion in annual purchasing volume. Through its Innovative Technology Program, Vizient works with client-led councils and task forces to evaluate products for their potential to bring real innovation to healthcare. If it is determined that a product is innovative, Vizient may award a contract outside of the competitive bid cycle.
Source: X-Bolt Orthopedics
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.
